Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBUKI: Inhaled Iloprost in Japanese PAH Patients
NCT01469169Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2012
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Bayer. Started Jun 2012; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01469169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469169.